David K. Rosen
Director/Board Member at Aruene Corp.
Profile
David K.
Rosen was the founder of Aratana Therapeutics, Inc. (founded in 2010) where he held the title of Chief Operating Officer from 2012 to 2013.
He currently holds director positions at Aruene Corp., Skyline Vet Pharma, Inc., and Amplifica Holdings Group, Inc. (California).
In the past, he has worked as a director at Ablative Solutions, Inc. and as an independent non-executive director at Parnell Pharmaceuticals Holdings Ltd.
He also served as the managing director at Adjacent Health Technologies, the head of the Corporate Licensing Division at Pfizer Inc., and as an entrepreneur-in-residence at MPM BioImpact, Inc. Dr. Rosen received his undergraduate degree from the University of Wisconsin and his doctorate from Iowa State University College of Veterinary Medicine.
David K. Rosen active positions
| Companies | Position | Start |
|---|---|---|
Aruene Corp.
 Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Director/Board Member | - |
Skyline Vet Pharma, Inc.
 Skyline Vet Pharma, Inc. Pharmaceuticals: MajorHealth Technology Skyline Vet Pharma, Inc. engages in the manufacture of veterinary pharmaceutical products. The company was founded by Serge R. Martinod and George F. Murphy and is headquartered in Groton, CT. | Director/Board Member | - |
Amplifica Holdings Group, Inc. (California)
 Amplifica Holdings Group, Inc. (California) Pharmaceuticals: MajorHealth Technology Amplifica Holdings Group, Inc. is a biopharmaceutical company based in San Diego, CA. Amplifica is focused on developing novel treatments for androgenic alopecia, a condition that affects millions of men and women. The company is taking a nature-inspired scientific approach to regrow natural hair by identifying and isolating unique signaling molecules that stimulate hair follicles. Amplifica is dedicated to developing novel therapeutics for hair regrowth. The company was founded by William Rassman, Maksim Plikus, Wajdie Ahmad, and the CEO is Frank M. Fazio. | Director/Board Member | - |
Former positions of David K. Rosen
| Companies | Position | End |
|---|---|---|
| PARNELL PHARMACEUTICALS HOLDINGS LTD | Director/Board Member | - |
| Adjacent Health Technologies | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Ablative Solutions, Inc.
 Ablative Solutions, Inc. Medical SpecialtiesHealth Technology Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA. | Director/Board Member | - |
| ARATANA THERAPEUTICS INC | Founder | - |
Training of David K. Rosen
| University of Wisconsin | Undergraduate Degree |
| Iowa State University College of Veterinary Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| PARNELL PHARMACEUTICALS HOLDINGS LTD | Health Technology |
| Private companies | 7 |
|---|---|
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Ablative Solutions, Inc.
Ablative Solutions, Inc. Medical SpecialtiesHealth Technology Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA. | Health Technology |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Aruene Corp.
Aruene Corp. Medical SpecialtiesHealth Technology Aruene Corp. develops portable, non-invasive Transcranial Magnetic Stimulation (TMS) devices for treatment of migraine. It offers SpringTMS, a transcranial magnetic stimulation device for the acute treatment of pain associated with migraine headache with aura. The company was founded by Robert E. Fischell and David R. Fischell in 2002 and is headquartered in Baltimore, MD. | Health Technology |
| Adjacent Health Technologies | |
Skyline Vet Pharma, Inc.
Skyline Vet Pharma, Inc. Pharmaceuticals: MajorHealth Technology Skyline Vet Pharma, Inc. engages in the manufacture of veterinary pharmaceutical products. The company was founded by Serge R. Martinod and George F. Murphy and is headquartered in Groton, CT. | Health Technology |
Amplifica Holdings Group, Inc. (California)
Amplifica Holdings Group, Inc. (California) Pharmaceuticals: MajorHealth Technology Amplifica Holdings Group, Inc. is a biopharmaceutical company based in San Diego, CA. Amplifica is focused on developing novel treatments for androgenic alopecia, a condition that affects millions of men and women. The company is taking a nature-inspired scientific approach to regrow natural hair by identifying and isolating unique signaling molecules that stimulate hair follicles. Amplifica is dedicated to developing novel therapeutics for hair regrowth. The company was founded by William Rassman, Maksim Plikus, Wajdie Ahmad, and the CEO is Frank M. Fazio. | Health Technology |
- Stock Market
- Insiders
- David K. Rosen
